10:28 AM EDT, 03/21/2024 (MT Newswires) -- Immunocore Holdings ( IMCR ) on Thursday filed a registration with the US Securities and Exchange Commission to sell securities from time to time.

The company and/or selling securityholders may offer ordinary shares, American depositary shares, debt securities, and warrants, the filing showed.

Proceeds will be used to fund the commercialization of products, clinical development of product candidates, and for other general corporate purposes, the firm said.

Price: 62.74, Change: -0.16, Percent Change: -0.25